secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNIVERSAL BIOSENSORS INC (—)
CIK:        0001279695
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001437749-25-001164
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Universal Biosensors appoints CEO Sharman and CFO Mullin to board; grants 25M options subject to approval
--------------------------------------------------------------------------------

- Board expanded from 4 to 6 members; CEO John Sharman (Class II) and CFO Peter Mullin (Class I) appointed directors effective Jan 15, 2025.
- Sharman granted 10M options: 5M at A$0.20 (2-yr vest) and 5M at A$0.30 (3-yr vest), subject to shareholder approval at 2025 AGM.
- Mullin granted 15M options: 5M at A$0.15 (1-yr), 5M at A$0.20 (2-yr), 5M at A$0.30 (3-yr vest), also subject to shareholder approval.
- Neither Sharman nor Mullin receives compensation for board service; only expense reimbursements.
- Sharman and Mullin are not independent directors under SEC or Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279695/000143774925001164/0001437749-25-001164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279695/000143774925001164/ubi20250114_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-001164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer